Sherman and Howard Client Ortho Agency Awarded Landmark Jury Verdict in Corporate‑Raiding Case

Medical-Device Distributor Wins Against Exactech and Former Sales Director for Takeover of Business Relationships, Misusing Trade Secrets and Poaching Contracted Sales Representatives

What To Know

  • Giarratano breached his contractor agreement with the company in a variety of ways, including violating non-disclosure of confidential and trade secret information, non‑competition, and non-solicitation provisions, including when he went to work for Exactech as a new distributor, and solicited and recruited Ortho Agency's sales personnel to work for his distributorship and Exactech.
  • “This is a defining verdict in the medical-device industry and sends a clear message that manufacturers in this field should not engage in conduct that interferes with their distributors' sales and customer relationships, or with the distributors' relationships with their sales representatives,” said Nick M.

Sherman and Howard announced a recent jury verdict in favor of its clients Michael Shatzer and The Ortho Agency LLC against its former sales director, Chad Giarratano, and global medical device manufacturer Exactech U.S., Inc., for allegedly collaborating to take over existing and prospective business relationships, violating contractual agreements with Ortho Agency, misusing Ortho Agency’s trade secrets, and poaching contracted sales representatives. Mr. Shatzer and Ortho Agency were represented by trial lawyers Peter G. Koclanes and Nick M. DeWeese.

Sherman and Howard  said after a five-day trial in Denver District Court, a jury found in favor of Mr. Shatzer and Ortho Agency on all of their claims, including that Exactech had breached an exclusive Sales Agency Agreement to sell its products to hospitals, surgeons and surgery centers in three states and portions of two others. The jury further found that Mr. Giarratano and his business entities had breached their Independent Services Agreement based upon the Defendants conducting a months-long stealth campaign to eliminate Mr. Shatzer and Ortho Agency as the exclusive distributor for Exactech in those territories and to take over their business. The jury awarded Mr. Shatzer and Ortho Agency $4,000,001.

“This jury verdict is a landmark decision in the medical-device industry where corporate raiding of smaller distributors’ business and personnel by large manufacturers occurs all too often,” said Peter G. Koclanes. “Given the dollar amount ordered by the jury, its verdict is one of the largest monetary awards for damages for a case of this kind in Colorado in the last several years.”

In addition to alleging that Exactech breached its Sales Agency Agreement, Ortho Agency alleged that Mr. Giarratano breached his contractor agreement with the company in a variety of ways, including violating non-disclosure of confidential and trade secret information, non‑competition, and non-solicitation provisions, including when he went to work for Exactech as a new distributor, and solicited and recruited Ortho Agency’s sales personnel to work for his distributorship and Exactech.

“This is a defining verdict in the medical-device industry and sends a clear message that manufacturers in this field should not engage in conduct that interferes with their distributors’ sales and customer relationships, or with the distributors’ relationships with their sales representatives,” said Nick M. DeWeese.

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

More News!

Reeva FT is offered in a variety of sizes: 2x2 cm, 2x3 cm, 4x4 cm, 4x6 cm, 4x8 cm, and 10x15 cm. Reeva FT is confirmed by the FDA Tissue Reference Group to meet the criteria for regulation solely under Section 361 of the PHS Act as defined in 21 CFR Part 1271.
The study is designed to assess the clinical utility and workflow benefits of Swoop® system images acquired at infusion centers and clinics to help physicians detect amyloid-related imaging abnormalities (ARIA) in Alzheimer’s patients receiving amyloid-targeting therapy at the times specified in the labeling (before the fifth, seventh, and fourteenth infusions).
“Tom and I have more than 50 years of experience,” Harp adds. “The decision to found Polymer Medical was done after careful consideration of the landscape and market opportunity; we will raise the level of competition and quality for customers.” Polymer Medical is located in a newly refurbished plant is at 168 Thorn Ave., Orchard Park, N.Y.
The RWE Program will expand Summus Laser's Class IV Laser Therapy research to generate validated and statistically significant datasets that will be used to enhance patient care, outcomes, and to further product innovations.
Details of the session: Polaroid Therapeutics & Avery Dennison Medical: How the power of partnership brings a novel approach to antimicrobial wound dressings.

By using this website you agree to accept Medical Device News Magazine Privacy Policy